Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation

Journal of Clinical Investigation

Volumn 93, Issue 5, 1994, Pages 1940-1947

  Salvemini, Daniela ^a   Seibert, Karen ^a   Masferrer, Jaime L ^a   Misko, Thomas P ^a   Currie, Mark G ^a   Needleman, Philip ^a  

^a MONSANTO COMPANY   (United States)

Author keywords

nitric oxide; prostaglandin E2; renal inflammation

Indexed keywords

CELL RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HYDRONEPHROSIS; KIDNEY FUNCTION; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RABBIT; URETER OBSTRUCTION;

EID: 0028268947     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117185     Document Type: Article

References (47)

1. 2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. J. Pharmacol. Exp. Ther. 205:1-8.
2. Mathias, C. J., M. J. Welsh, D. B. Schwartz, S. M. Spaethe, and P. Needleman. 1989. Differentiation in vivo of the sequential blood cell invasion following ureter obstruction of the rabbit kidney. J. Nucl. Med. Biol. 16:25-32.
3. Nagle, R. B., R. E. Bulger, R. E. Cutler, H. R. Jervis, and E. P. Benditt. 1973. Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. Lab. Invest. 28:456-467.
4. Nagle, R. B., M. E. Johnson, and H. R. Jervis. 1976. Proliferation of renal interstitial cells following injury induced by ureteral obstruction. Lab. Invest. 35:18-22.
5. Okegawa, T., P. E. Jonas, K. DeSchryver, A. Kawasaki, and P. Needleman. 1983. Metabolic and cellular alterations underlying the exagerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells. J. Clin. Invest. 71:81-90.
6. 2 synthesis by ureteral obstruction in the rabbit kidney. Nature (Lond.). 267:259-260.
7. Wu, Y. S., T. Lysz, A. Wyche, and P. Needleman. 1983. Kinetic comparison and regulation of the cascade of microsomal enzymes involved in renal arachidonate and endoperoxide metabolism. J. Biol. Chem. 258:2188-2192.
8. Nishikawa, K., A. Morrison, and P. Needleman. 1977. Exagerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney. J. Clin. Invest. 59:1143-1150.
9. Needleman, P., A. Wyche, S. D. Bronson, S. Holmberg, and A. R. Morrison. 1979. Specific regulation of peptide-induced renal prostaglandin synthesis. J. Biol. Chem. 254:9772-9777.
10. Kawasaki, A., and P. Needleman. 1982. Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic kidney. Circ. Res. 50:486-490.
11. Lefkowith, J. B., T. Okegawa, K. DeSchryver-Kecskemeti, and P. Needleman. 1984. Macrophage-dependent arachidonate metabolism in hydronephrosis. Kidney. Int. 26:10-17.
12. 2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem 265:16737-16740.
13. Masferrer, J. L., B. S. Zweifel, K. Seibert, and P. Needleman. 1990. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest. 86:1375-1379.
14. Masferrer, J. L., K. Seibert, B. Zweifel, and P. Needleman. 1992. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. USA. 89:3917-3921.
15. Raz, A., A. Wyche, N. Siegel, and P. Needleman. 1988. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J. Biol. Chem. 263:3022-3028.
16. Maier, J. A. M., T. Hla, and T. Maciag. 1990. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265:10805-10808.
17. Salvemini, D., T. P. Misko, J. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:7240-7244.
18. Angus, J. A., and T. M. Cocks. 1989. Endothelium-derived relaxing factor. Pharmacol. Ther. 41:303-352.
19. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-141.
20. Crack, P., and T. Cocks. 1992. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery. Br. J. Pharmacol. 107:566-572.
21. Radomski, M. W., R. M. J. Palmer, and S. Moncada. 1990. Glucocorticoids inhibit the expression of an inducible but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 87:10043-10047.
22. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J. C. Stoclet. 1990 Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259:H1038-H1043.
23. Mollace, V., D. Salvemini, E. Anggard, and J. Vane. 1991. Nitnc oxide from smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br. J. Pharmacol. 104:633-638.
24. Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 29:8706-8711.
25. Salvemini, D., R. Korbut, and J. R. Vane. 1990. NG-monomethyl-L-arginine inhibits the release of a nitric oxide-like substance induced by E. coli lipopolysaccharide in the mouse macrophage cell line, J774. In Nitric Oxide from L-Arginine: A Bioregulatory System. S. Moncada and E. A. Higgs, editors. Excerpta Medica, Amsterdam. 267-274.
26. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster, Jr., J. R. Williamson, and M. L. McDaniel. 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:552-556.
27. Misko, T. P., W. M. Moore, T. P. Kasten, G. A. Nickols, J. A. Corbett, R. G. Tilton, M. L. McDaniel, J. R. Williamson, and M. G. Currie. 1993a. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-125.
28. Griffith, M. J. D., M. Messent, R. J. MacAllister, and T. W. Evans. 1993. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J Pharmacol. 110:963-968.
29. Bhardwaj, R., and P. K. Moore. 1989. The effects of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Br. J. Pharmacol. 97:739-744.
30. Feben Reigold, D., K. Watters, S. Holberg, and P. Needleman. 1981. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys. J. Pharmacol. Exp. Ther. 216:510-515.
31. Misko, T. P., R. J. Schilling, D. Salvemini, W. M. Moore, and M. G. Currie. 1993b. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:11-16.
32. Karthein, R., W. Nastainczyk, and H. H. Ruf. 1987. EPR study of ferric native prostaglandin H synthase and its ferrous NO derivative. Eur. J. Biochem. 166:173-180.
33. Kanner, J., S. Harel, and R. Granit. 1991. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289:130-136.
34. Egan, R. W., J. Paxton, and F. A. Kuehl, Jr. 1976. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J. Biol. Chem. 251:7329-7335.
35. Currie, M., A. Kawasaki, P. Jonas, B. Davis, and P. Needleman. 1982. The mechanism and site of the enhanced arachidonate metabolism in ureter obstruction. In Prostaglandins and the kidney. M. J. Dunn, C. Patrono, and A. Cinotti, editors Plenum Publishing Corp., New York. 28:299-308.
36. Lefkowith, J. B., and P. Needleman. 1985. Arachidonate metabolism in renal injury. In Advances in Prostaglandin, Thromboxane, and Leukotriene Research. O. Hayaishi and S. Yamamoto, editors. Raven Press, New York. 13:121-130.
37. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB. J. 6:3051-3064.
38. Cattell, V., T. Cook, and S. Moncada. 1990. Glomeruli synthesize nitrite in experimental nephrotoxic nephritis. Kidney Int. 38:1056-1060.
39. Cook, H. Y., and R. Sullivan. 1991. Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat. Am. J Pathol. 139:1047-1052.
40. Jansen, A., S. Lewis, V. Cattell, and H. T. Cook. 1992. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int. 42:1107-1112.
41. Katsuki, S., W. P. Arnold, C. K. Mittal, and F. Murad. 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3:23-35.
42. Rapoport, R. M., M. D. Draznin, and F. Murad. 1983. Endothelium-dependent vasodilator- and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation. Trans. Assoc. Am. Physicians. 26:19-30.
43. Ignarro, L. J., and H. Lippton. 1980. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite-possible involvement of S-nitrosothiols. Biochim. Biophys. Acta. 631:221-231.
44. Ignarro, L. J., H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. 1981. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-749.
45. Feelisch, M. 1991. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspect of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:S25-S33.
46. Luscher, T. F., and H. A. Bock. 1991. The endothelial L-arginine/nitric oxide pathway and the renal circulation. Klin. Wochenschr. 69:603-609.
47. King, A. J., and B. M. Brenner. 1991. Endothelium-derived vasoactive factors and the renal vasculature. Am. J. Physiol. 260:R653-R662.